Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2011 - 2026)

Sarepta Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.67 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 53.24% year-over-year to 0.67 in Q1 2026; TTM through Mar 2026 was 0.67, a 53.24% increase from a year earlier, with the FY2025 full-year figure at 0.51, down 3.12% from the prior year.
• Asset Utilization Ratio advanced to 0.67 in Q1 2026 per SRPT's latest filing, from 0.46 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.67 in Q1 2026 and bottomed at 0.18 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.5 (2024), against an average of 0.49.
• Across the five-year window, Asset Utilization Ratio jumped 178.51% in 2023 and slumped 31.3% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.48 in 2022, then grew by 23.86% to 0.59 in 2023, then slipped by 14.74% to 0.5 in 2024, then decreased by 7.8% to 0.46 in 2025, then jumped by 44.29% to 0.67 in 2026.
• Per Business Quant, the three latest SRPT Asset Utilization Ratio figures stand at 0.67 (Q1 2026), 0.46 (Q4 2025), and 0.5 (Q3 2025).